rendering of small molecules

Mobile Community Research Sites

As part of our commitment to patient-centric solutions, in early 2022 we began partnering with EmVenio to bring clinical trials directly to patients via mobile community research sites, decreasing patient burden and allowing us to offer more creative strategies to our customers. These specialized sites equip us to screen, recruit and retain trial participants, including previously under-represented and under-served communities, while ensuring a positive patient experience.

Learn more about our digital and decentralized solutions.